← All organizations

Inhibikase Therapeutics, Inc.

For profitWebsite ↗

Also known as: Inhibikase Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 30, 2025

Timeline

2000s

Jun 1, 2008
Inhibikase Therapeutics, Inc.— Founded

Drugs by trial phase (3 distinct, 6 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

itraconazole

Recent trials (7)

NCT06643143Lead sponsorPhase 2Jun 30, 2025
NCT06644326Lead sponsorPhase 1Jun 21, 2023
NCT06641557Lead sponsorPhase 1Feb 21, 2023
NCT05623774Lead sponsorPhase 1Nov 30, 2022
NCT05424276Overall official - principal investigatorPhase 2May 23, 2022
NCT05424276Lead sponsorPhase 2May 23, 2022
NCT04350177Lead sponsorPhase 1Jul 1, 2020

Details

Founded: Atlanta, GA, US Jun 1, 2008
Last known activity: Jun 30, 2025